Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2006; 12(31): 5055-5059
Published online Aug 21, 2006. doi: 10.3748/wjg.v12.i31.5055
Table 1 Comparison of clinical and biochemical data pre-and post MARS treatment
ParameterPre-treatmentPost-treatmentP value
Prognostic scores
SOFA score (points)9.72 ± 1.896.98 ± 2.34< 0.01
Glasgow coma score (points)7.23 ± 1.2113.34 ± 2.33< 0.01
Clinical and biochemical parameters
MAP (mmHg)70.5 ± 12.185.1 ± 10.4< 0.001
TNF-α (pg/mL)2.83 ± 1.71.80 ± 1.39< 0.01
IL-10 (pg/mL)7.80 ± 6.04.5 ± 4.5< 0.05
ALT295.7 ± 1125.4237.14 ± 91.82< 0.036
TBIL (μmol/L)341.16 ± 94.93232.74 ± 169.29< 0.04
TBA (mmol/L)162 ± 10473 ± 51< 0.001
Albumin (g/L)35.5 ± 35.735.7 ± 6.8> 0.05
INR4.66 ± 3.353.98 ± 3.16> 0.05
Cr (μmol/L)128.67 ± 87.7333.21 ± 22.26< 0.045
Ammonia (mmol/L)151.31 ± 88.9928.28 ± 20.19< 0.028
Table 2 Risk factors relating to early mortality after liver transplantation
GroupnAgeaSOFAbGSHaMAPaTNF-αaIL-10aINRaCreatinineb
Survival2834.34 ± 2.458.18 ± 1.2312.45 ± 2.2683.7 ± 10.011.99 ± 1.45.5 ± 2.03.34 ± 1.8945.45 ± 12.12
Death645.56 ± 2.369.88 ± 1.099.88 ± 2.4375.0 ± 12.462.34 ± 1.056.2 ± 2.94.77 ± 2.07110.34 ± 23.65
Table 3 Stepwise logistic regression analysis
VariablesBSEWaldDfSigR
SOFA2.6380.8795.87910.0180.224
Creatinine5.8221.3518.34510.0020.315
TNF-Α-α2.1310.7755.66410.0190.192
IL-102.0140.7664.78410.0250.188
INR3.4551.3358.02510.0020.309